Literature DB >> 20672328

Expression, localization, and regulation of the neuregulin receptor ErbB3 in mouse heart.

Genís Campreciós1, Jordi Lorita, Eva Pardina, Julia Peinado-Onsurbe, Maria Soley, Ignasi Ramírez.   

Abstract

Neuregulins (NRG) belong to the EGF family of growth factors, which are ligands of the ErbB receptors. Their expression in the adult heart is essential, especially when the heart is submitted to cardiotoxic stress such as that produced by anthracyclines. It is considered that ErbB4 is the only NRG receptor expressed by the adult heart. Upon binding, ErbB4 may dimerize with ErbB2 to generate signals inside cells. However, here we show the presence of ErbB3 in the mouse heart from birth to adulthood by Western blotting and real-time RT-PCR. The expression level of ErbB3 mRNA was lower than that of ErbB2 or ErbB4, but was more stable throughout postnatal development. In isolated heart myocytes, ErbB3 localized to the Z-lines similarly to ErbB1. Perfusion of isolated hearts with NRG-1β induced phosphorylation of ErbB3, as well as ErbB2 and ErbB4. In adult mice, both ErbB2 and ErbB3, but not ErbB1 or ErbB4, were rapidly down-regulated upon the induction of heart hypertrophy. In conclusion, our results demonstrate that ErbB3, in addition to ErbB4, is a receptor for neuregulin-1β in the adult mouse heart.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20672328     DOI: 10.1002/jcp.22354

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  The Src homology and collagen A (ShcA) adaptor protein is required for the spatial organization of the costamere/Z-disk network during heart development.

Authors:  Mohamed Mlih; Lionel Host; Sophie Martin; Nathalie Niederhoffer; Laurent Monassier; Jérôme Terrand; Nadia Messaddeq; Michael Radke; Michael Gotthardt; Véronique Bruban; Frank Kober; Monique Bernard; Emmanuelle Canet-Soulas; Francisco Abt-Jijon; Philippe Boucher; Rachel L Matz
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

2.  Effects of radiation on the epidermal growth factor receptor pathway in the heart.

Authors:  Vijayalakshmi Sridharan; Sunil K Sharma; Eduardo G Moros; Peter M Corry; Preeti Tripathi; Benjamin J Lieblong; Chandan Guha; Martin Hauer-Jensen; Marjan Boerma
Journal:  Int J Radiat Biol       Date:  2013-04-16       Impact factor: 2.694

Review 3.  Emerging paradigms in cardiomyopathies associated with cancer therapies.

Authors:  Bonnie Ky; Pimprapa Vejpongsa; Edward T H Yeh; Thomas Force; Javid J Moslehi
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 4.  Neuregulin in cardiovascular development and disease.

Authors:  Oghenerukevwe Odiete; Michael F Hill; Douglas B Sawyer
Journal:  Circ Res       Date:  2012-10-26       Impact factor: 17.367

Review 5.  Mechanisms and potential interventions associated with the cardiotoxicity of ErbB2-targeted drugs: Insights from in vitro, in vivo, and clinical studies in breast cancer patients.

Authors:  Krit Leemasawat; Arintaya Phrommintikul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Cell Mol Life Sci       Date:  2019-10-24       Impact factor: 9.261

Review 6.  Thirty Years of HER3: From Basic Biology to Therapeutic Interventions.

Authors:  Heidi M Haikala; Pasi A Jänne
Journal:  Clin Cancer Res       Date:  2021-02-19       Impact factor: 12.531

Review 7.  ErbB2 signaling at the crossing between heart failure and cancer.

Authors:  Zarha Vermeulen; Vincent F M Segers; Gilles W De Keulenaer
Journal:  Basic Res Cardiol       Date:  2016-09-05       Impact factor: 17.165

Review 8.  Neuregulin-1, a potential therapeutic target for cardiac repair.

Authors:  Yan Wang; Jianliang Wei; Peng Zhang; Xin Zhang; Yifei Wang; Wenjing Chen; Yanan Zhao; Xiangning Cui
Journal:  Front Pharmacol       Date:  2022-08-31       Impact factor: 5.988

9.  Neuregulin 1 Improves Glucose Tolerance in db/db Mice.

Authors:  Gaël Ennequin; Nathalie Boisseau; Kevin Caillaud; Vivien Chavanelle; Monique Etienne; Xinyan Li; Pascal Sirvent
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

Review 10.  Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease.

Authors:  Andrew Geissler; Sergey Ryzhov; Douglas B Sawyer
Journal:  Clin Sci (Lond)       Date:  2020-10-16       Impact factor: 6.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.